Exclusive updates and insights on healthcare innovation and Chinese market straight to your inbox

October 24, 2025
Starna Therapeutics secures over ¥300M in Series B funding to advance in vivo CAR-T pipelineThe proceeds will be primarily used to upgrade and expand the company's extrahepatic targeted delivery platform, accelerate the clinical development of its in vivo CAR-T pipeline, and further solidify the company's innovative positioning in the field of RNA therapeutics.
October 22, 2025
Huaxi Intelligence raises new funding for essential elderly care robots October 21, 2025
Cygnus Biosciences closes new funding round exceeding 100M yuan